SCHEMBL27655992

SCHEMBL27655992

O=C(O)N1CCN(C(=O)C(c2ccc(Br)cc2)C2(O)CCCCC2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.39
NPSR1 Q6W5P4 2/20 0.39
HPGD P15428 1/20 0.38
CHRM2 P08172 2/20 0.36
CHRM1 P11229 2/20 0.36
CHRM3 P20309 2/20 0.36
CHRM4 P08173 1/20 0.36
CCR1 P32246 1/20 0.36
OPRM1 P35372 2/20 0.36
OPRD1 P41143 2/20 0.36
OPRK1 P41145 1/20 0.36
OPRL1 P41146 1/20 0.36
POLB P06746 2/20 0.35
ALDH1A1 P00352 2/20 0.35
ACE2 Q9BYF1 1/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ROCK2 O75116 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27675975 0.96 NPSR1 (0.40) LMNANPSR1HPGDCHRM2CHRM1
SCHEMBL4624849 0.88 SLC6A2 (0.41) LMNANPSR1HPGDCHRM2CHRM1
SCHEMBL27681435 0.87 SLC6A2 (0.43) LMNAHPGDCCR1ALDH1A1MEN1
SCHEMBL27661851 0.87 SLC6A2 (0.43) OPRM1OPRD1OPRK1OPRL1NPC1
SCHEMBL5695482 0.85 ALDH1A1 (0.39) LMNANPSR1HPGDCHRM2CHRM1
SCHEMBL27681429 0.83 SLC6A2 (0.39) LMNAHPGDALDH1A1SMN1; SMN2
SCHEMBL3955198 0.82 ESRRB (0.44) LMNAALDH1A1MEN1MAPTKMT2A
SCHEMBL27655996 0.81 ALDH1A1 (0.40) LMNANPSR1HPGDCHRM3ALDH1A1
SCHEMBL27662478 0.81 SLC6A2 (0.49)
SCHEMBL27656082 0.80 LMNA (0.41) LMNANPSR1HPGDCHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1972920-A Arylalkyl piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms WYETH CORP (US) 2007-05-30 CN disclosed
CN-1894226-A Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use WYETH CORP (US) 2007-01-10 CN disclosed